Skip to main content

Promising leukemia drug trial pushes Gilead stock higher

Gilead Sciences Inc. stock continued to climb Thursday after the company stopped a study of an experimental leukemia treatment because patients had substantially improved...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.